MASH VIEW
LIVE

Serial Number

99078464

Owner

Tensor Biosciences, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Mar 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MASH VIEW Trademark

Serial Number: 99078464

MASH VIEW is a trademark filed by Tensor Biosciences, Inc. on March 11, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Tensor Biosciences, Inc. (4 trademarks)

3128 David Avenue
Palo Alto, CA 94303

Entity Type: 03

Trademark Details

Filing Date

March 11, 2025

Registration Date

Not Registered

Published for Opposition

March 3, 2026

Goods & Services

liquid biopsy test kits comprising reagents, enzymes, nucleotides, and assays to be for scientific and medical research purposes; diagnostic preparations for clinical or medical laboratory use, namely, diagnostic preparations for scientific or research laboratory use

diagnostic kits in the nature of liquid biopsy tests comprised of medical diagnostic reagents, nucleotides, solvents, enzymes, and assays for testing of bodily fluids for use in disease detection and testing; diagnostic kits in the nature of liquid biopsy tests comprised of medical diagnostic reagents for diagnosing and monitoring metabolic, chronic, liver, and kidney diseases and disorders; medical diagnostic tests in the nature medical diagnostic reagents and assays and medical diagnostic test strips to diagnose and monitor liver and kidney diseases and disorders; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical purposes

diagnostic kits in the nature of liquid biopsy tests in the nature of medical diagnostic apparatus for testing DNA and cancer cells for diagnosing and monitoring metabolic, chronic, liver, and kidney diseases and disorders; medical diagnostic tests in the nature of medical diagnostic apparatus for testing DNA and cancer cells to diagnose and monitor liver and kidney diseases and disorders

medical testing for diagnostic or treatment purposes; medical diagnostic screening and analytical services in the field of medical diagnostic testing; predictive medical analysis services for the diagnosis and treatment of persons

Medical and scientific research, namely, diagnostic testing for research and development, clinical trials and clinical laboratory services; research in the field of molecular diagnostics

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 28, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 28, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 13, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 11, 2025 MAFR
NEW APPLICATION ENTERED
Mar 11, 2025 NWAP